Investigational New Drug (IND)

Showing: 1 - 1 of 1 Articles

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) application for VNT-101, a novel direct-acting antiviral against Influenza A virus

Via Nova Therapeutics, Inc., a biotechnology company focused on discovering and developing therapeutics to treat …